Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,012
datasets available to search
ShareScore release 0.9.0
Dataset results
2,012 results for “Kinase”
Study of TQ-B3139 in Subjects With Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) Previously Treated With Crizotinib
ClinicalTrials.gov study NCT04056572. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multicentre Study to Explore the Correlation Between Smoking Pattern and Clinical Efficacy of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Male Patients
ClinicalTrials.gov study NCT00922025. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of XRD-0394, a Kinase Inhibitor, in Combination With Palliative Radiotherapy in Advanced Cancer Patients
ClinicalTrials.gov study NCT05002140. IPD Sharing: NO. Countries: 1. Publications: 0.
Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate Activities in Red Blood Cells of People With Sickle Cell Disease
ClinicalTrials.gov study NCT03685721. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ruxolitinib in Treating Participants With Chronic Myeloid Leukemia With Minimal Residual Disease While on Therapy With Tyrosine Kinase Inhibitors
ClinicalTrials.gov study NCT01751425. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States
ClinicalTrials.gov study NCT03045120. IPD Sharing: NO. Countries: 1. Publications: 0.
Determinants of Resistance to Endocrine Therapy and a Cyclin-dependent Kinases 4 and 6 (CDK4/6) Inhibitor for HR+ MBC
ClinicalTrials.gov study NCT03439735. IPD Sharing: NO. Countries: 1. Publications: 0.
Dietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase Deficiency
ClinicalTrials.gov study NCT00260299. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Potential Relationship Between Treatment With Tyrosine Kinase Inhibitors and Erectile Dysfunction in Male Patients With Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT07061145. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of the Efficacy and Safety of Alectinib in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT03155009. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease
ClinicalTrials.gov study NCT07281456. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of TG-1701, an Irreversible Bruton's Tyrosine Kinase Inhibitor, in Patients With B-Cell Malignancies
ClinicalTrials.gov study NCT03671590. IPD Sharing: NO. Countries: 2. Publications: 0.
A Study to Evaluate Effectiveness and Safety of Tyrosine Kinase Inhibitors
ClinicalTrials.gov study NCT03424980. IPD Sharing: NO. Countries: 1. Publications: 0.
Rho Kinase (ROCK) Inhibitor in Tauopathies - 1
ClinicalTrials.gov study NCT04734379. IPD Sharing: NO. Countries: 1. Publications: 0.
Treatment Registry of Alectinib in Anaplastic Lymphoma Kinase (ALK)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer in Korea
ClinicalTrials.gov study NCT03271554. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Treatment-naive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT02556892. IPD Sharing: Not stated. Countries: 1. Publications: 0.
MEVALONATE KINASE GENE MUTATIONS AND THEIR CLINICAL CORRELATIONS IN BEHÇET'S DISEASE
ClinicalTrials.gov study NCT01780363. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Janus Kinase Inhibition in Granuloma Annulare
ClinicalTrials.gov study NCT05650736. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Regularly Transfused, Followed by a 5-Year Extension Period
ClinicalTrials.gov study NCT05144256. IPD Sharing: NO. Countries: 10. Publications: 0.
A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients with Advanced or Metastatic Solid Tumors
ClinicalTrials.gov study NCT05983523. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.